Evidence map›Paper›PMID 24744379›Full record

ArticleScience (New York, N.Y.)2014

Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience.

Allyson K Friedman, Jessica J Walsh, Barbara Juarez, Stacy M Ku, Dipesh Chaudhury, Jing Wang, Xianting Li, David M Dietz, Nina Pan, Vincent F Vialou and 3 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 274 papers.

0numbers the graph read from it
0cells of the map it votes in
274citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

274 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. New Antidepressant Development in the Treatment of Depression.Advances in experimental medicine and biology · 2026
    Review
  19. Article
  20. Review

214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Allyson K FriedmanDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jessica J Walsh
Barbara Juarez
Stacy M Ku
Dipesh Chaudhury
Jing Wang
Xianting Li
David M Dietz
Nina Pan
Vincent F Vialou
Rachael L Neve
Zhenyu Yue
Ming-Hu Han

Funding

REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELSP50MH096890 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI NESTLER, ERIC J. · 2012 to 2021
$20.2M
Training Program in Basic NeuroscienceT32MH020016 · NIMH · STANFORD UNIVERSITY · PI Justin L Gardner, Merritt C Maduke · 1997 to 2026
$16.2M
Neuronal Autophagy: a Cell-Autonomous Protection MechanismR01NS060123 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Zhenyu Yue · 2008 to 2026
$9.2M
Training Program in NeuroscienceT32MH087004 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GEORGE W. HUNTLEY · 2009 to 2026
$4.0M
Neurophysiological Basis of Susceptibility and Resilience to Social Defeat StressR01MH092306 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAN, MING-HU · 2011 to 2015
$2.1M
Neurophysiological Mechanisms of Variable Alcohol Drinking BehaviorsR01AA022445 · NIAAA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAN, MING-HU · 2014 to 2018
$1.7M
Training Program in Mental Health ResearchT32MH096678 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R, SHAPIRO, MATTHEW L · 2012 to 2016
$1.1M
Ih and K+ Channels as Mechanistically Novel Targets for Depression TreatmentF32MH096464 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRIEDMAN, ALLYSON KIMBERLY · 2011 to 2013
$163k
Dissecting Lateral Hypothalamic Input to Midbrain Neurons and its Role in Social Defeat StressF31MH108326 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KU, STACY · 2016 to 2017
$72k
Neural Circuit Basis of Behavioral Susceptibility and Resilience to Social DefeatF31MH095425 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WALSH, JESSICA JILLIAN · 2012 to 2013
$44k
NIAAA NIH HHS R01 AA022445NIMH NIH HHS F31 MH095425NIMH NIH HHS F31 MH108326NIMH NIH HHS F32 MH096464NIMH NIH HHS P50 MH096890NIMH NIH HHS R01 MH092306NIMH NIH HHS T32 MH020016NIMH NIH HHS T32 MH 087004NIMH NIH HHS T32 MH087004NIMH NIH HHS T32 MH096678NINDS NIH HHS R01 NS060123
6 · The paper itself

Abstract

Typical therapies try to reverse pathogenic mechanisms. Here, we describe treatment effects achieved by enhancing depression-causing mechanisms in ventral tegmental area (VTA) dopamine (DA) neurons. In a social defeat stress model of depression, depressed (susceptible) mice display hyperactivity of VTA DA neurons, caused by an up-regulated hyperpolarization-activated current (I(h)). Mice resilient to social defeat stress, however, exhibit stable normal firing of these neurons. Unexpectedly, resilient mice had an even larger I(h), which was observed in parallel with increased potassium (K(+)) channel currents. Experimentally further enhancing Ih or optogenetically increasing the hyperactivity of VTA DA neurons in susceptible mice completely reversed depression-related behaviors, an antidepressant effect achieved through resilience-like, projection-specific homeostatic plasticity. These results indicate a potential therapeutic path of promoting natural resilience for depression treatment.

Indexed as

Resilience, PsychologicalAnimalsBehavior, AnimalDepressionDopaminergic NeuronsElectrophysiological PhenomenaHomeostasisHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsLamotrigineMaleMembrane PotentialsMiceMice, Inbred C57BLMice, TransgenicOptogeneticsPatch-Clamp TechniquesHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsLamotriginePotassium ChannelsTriazines

Identifiers

PMID24744379
PMCPMC4334447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.